Related Experiment Videos
Hypertension and the ischaemic myocardium
Summary
Silent myocardial ischaemia, often missed, impacts prognosis and treatment. This condition, prevalent in hypertension and ischaemic heart disease, requires active detection for effective management of coronary events.
Area of Science:
- Cardiology
- Clinical Medicine
Background:
- Hypertension and ischaemic heart disease frequently coexist.
- Myocardial ischaemia may occur without the typical symptom of angina pectoris.
- Silent myocardial ischaemia has significant prognostic and therapeutic implications if not actively identified.
Purpose of the Study:
- To highlight the importance of detecting silent myocardial ischaemia.
- To discuss the implications of silent ischaemia in both stable and unstable angina.
- To review the therapeutic effects of common anti-anginal agents on both painful and painless ischaemia.
Main Methods:
- Ambulatory ST-segment monitoring.
- Haemodynamic monitoring.
- Review of studies on beta-blockers, calcium antagonists, and nitrates in angina.
Main Results:
- Transient myocardial ischaemia can occur without chest pain and may be overlooked.
- Pharmacological agents for angina show similar efficacy in both painful and painless ischaemia.
- Silent ischaemia is a significant predictor of future coronary events in unstable angina.
Conclusions:
- Active investigation for silent myocardial ischaemia is crucial for patients with ischaemic heart disease.
- Recognizing and managing silent ischaemia can improve patient outcomes.
- Further research is needed on the prognostic implications of silent ischaemia in stable angina.